Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Probiotics are proposed to positively modulate the intestinal epithelial barrier formed by intestinal epithelial cells (IECs) and intercellular junctions. Disruption of this border alters paracellular permeability and is a key mechanism for the development of enteric infections and inflammatory bowel diseases (IBDs). METHODOLOGY AND PRINCIPAL FINDINGS: To study the in vivo effect of probiotic Escherichia coli Nissle 1917 (EcN) on the stabilization of the intestinal barrier under healthy conditions, germfree mice were colonized with EcN or K12 E. coli strain MG1655. IECs were isolated and analyzed for gene and protein expression of the tight junction molecules ZO-1 and ZO-2. Then, in order to analyze beneficial effects of EcN under inflammatory conditions, the probiotic was orally administered to BALB/c mice with acute dextran sodium sulfate (DSS) induced colitis. Colonization of gnotobiotic mice with EcN resulted in an up-regulation of ZO-1 in IECs at both mRNA and protein levels. EcN administration to DSS-treated mice reduced the loss of body weight and colon shortening. In addition, infiltration of the colon with leukocytes was ameliorated in EcN inoculated mice. Acute DSS colitis did not result in an anion secretory defect, but abrogated the sodium absorptive function of the mucosa. Additionally, intestinal barrier function was severely affected as evidenced by a strong increase in the mucosal uptake of Evans blue in vivo. Concomitant administration of EcN to DSS treated animals resulted in a significant protection against intestinal barrier dysfunction and IECs isolated from these mice exhibited a more pronounced expression of ZO-1. CONCLUSION AND SIGNIFICANCE: This study convincingly demonstrates that probiotic EcN is able to mediate up-regulation of ZO-1 expression in murine IECs and confer protection from the DSS colitis-associated increase in mucosal permeability to luminal substances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Administration of EcN in DSS induced colitis. (A) Disease severity was measured daily and is expressed in terms of body weight loss. (group II: n = 23, group III: n = 25, group I: n = 17) *p<0.05 group III vs. group II. (B) Reduction of colon length. Measurement of colon length [cm] after preparation. (group II: n = 24, group III: n = 25, group I: n = 13) *p<0.05 group III vs. group II or group III vs. group I **p<0.01 group II vs. group I. (C) Infiltration of hematopoietic cells into the colon. Whole intestinal cell populations were labeled with anti-CD45 APC antibody and measured by FACS analysis (n = 6/group).](https://figures.cochat.ai/paper-figures/a1148e572e0d4e349121af67e3f53f94/probiotic-escherichia-coli-nissle-1917-inhibits-leaky-gut-by-enhancing-mucosal-figure-4.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microbes(Figure 3) can directly alter expression of tight junction proteins such as claudin-380 and zonula occludens-181 or enhance expression of genes involved in tight junction signaling82.”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA
Farquhar, M. G., & Palade, G. E. (1963) · The Journal of Cell Biology · doi:10.1083/jcb.17.2.375 · Cited by 3,635 · cited 1×
“Its effectiveness and stability are ensured by the junctional complex [1].”
BackgroundPodolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
Stevenson, B. R., Siliciano, J. D., Mooseker, M. S., & Goodenough, D. A. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.3.755 · Cited by 1,638 · cited 1×
“The first junction-associated protein identified was zonula occludens 1 (ZO-1), with a molecular mass between ,210–225 kDa [5].”
BackgroundKruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · cited 2×
“characterized probiotics, and its therapeutic efficacy and safety have convincingly been proven [12–16].”
BackgroundRembacken, B., Snelling, A., Hawkey, P., Chalmers, D., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,101
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,052 · cited 10×
“A potential mechanism by which probiotics may exhibit their beneficial activities is modulation of the epithelial barrier function [17,18].”
BackgroundInfluentialRachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.019 · Cited by 859 · cited 1×
“In the past years, probiotics have been shown to be effective in the treatment of mild to moderately active IBD [18] and to reduce inflammation in animal models of colitis [29,34–36].”
BackgroundKRUIS, W., SCHÜTZ, E., FRIC, P., FIXA, B., JUDMAIER, G., & STOLTE, M. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00225.x · Cited by 775 · cited 2×
“characterized probiotics, and its therapeutic efficacy and safety have convincingly been proven [12–16].”
BackgroundOrla-Jensen, S. (1919) · Cited by 698
Wang, F., Graham, W. V., Wang, Y., Witkowski, E. D., Schwarz, B. T., & Turner, J. R. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62264-x · Cited by 696 · cited 2×
“It has been shown that the impaired barrier function in IBD is associated with an altered TJ structure [7,8,25–28].”
BackgroundElectrolyte transport in the mammalian colon: mechanisms and implications for disease
Kunzelmann, K., & Mall, M. (2002) · Physiological Reviews · doi:10.1152/physrev.00026.2001 · Cited by 655 · cited 1×
“Na absorption is mediated by electroneutral (apical Na/H exchangers NHE3 and possibly NHE2) and electrogenic (apical Na channel ENaC) pathways in the colon [37].”
BackgroundResta-Lenert, S., & Barrett, K. E. (2003) · Gut · doi:10.1136/gut.52.7.988 · Cited by 642 · cited 1×
“coli and enhance intestinal epithelial barrier function by amplifying phosphorylation of occludin and ZO-1 in vitro [19].”
BackgroundIntestinal permeability and the prediction of relapse in Crohn's disease
Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626 · cited 1×
“It has been shown that the impaired barrier function in IBD is associated with an altered TJ structure [7,8,25–28].”
BackgroundSchmitz*, H., Barmeyer*, C., Fromm‡, M., Runkel§, N., Foss∥, H.-D., Bentzel¶, C. J., Riecken*, E.-O., & Schulzke*, J.-D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70126-5 · Cited by 607 · cited 2×
“Active fluid absorption is also dependent on intact tight junctions, otherwise a phenomenon called ‘‘leak flux diarrhea’’ occurs [39–41].”
BackgroundVibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.
Fasano, A., Baudry, B., Pumplin, D. W., Wasserman, S. S., Tall, B. D., Ketley, J. M., & Kaper, J. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5242 · Cited by 579 · cited 1×
“Searching for the causative agent led to the detection of the ZOT, a toxin which causes a disruption of the tight junctions in isolated intestine [44].”
BackgroundIdentification of a 160-kDa polypeptide that binds to the tight junction protein ZO-1.
Gumbiner, B., Lowenkopf, T., & Apatira, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3460 · Cited by 523 · cited 1×
“protein that forms a complex together with ZO-1 [9] and has recently been shown to be up-regulated by EcN in vitro [10].”
BackgroundProtein Interactions at the Tight Junction
Wittchen, E. S., Haskins, J., & Stevenson, B. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35179 · Cited by 480 · cited 1×
“This molecule constitutes the structural link between the cytoskeleton and the tight junction by binding to both actin filaments and the TJ protein occludin [6].”
BackgroundMcCarthy, J., O’Mahony, L., O’Callaghan, L., Sheil, B., Vaughan, E. E., Fitzsimons, N., Fitzgibbon, J., O’Sullivan, G. C., Kiely, B., Collins, J. K., et al. (2003) · Gut · doi:10.1136/gut.52.7.975 · Cited by 462 · cited 1×
“In the past years, probiotics have been shown to be effective in the treatment of mild to moderately active IBD [18] and to reduce inflammation in animal models of colitis [29,34–36].”
BackgroundMa, T. Y., Boivin, M. A., Ye, D., Pedram, A., & Said, H. M. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2004 · Cited by 452
Zyrek, A. A., Cichon, C., Helms, S., Enders, C., Sonnenborn, U., & Schmidt, M. A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00836.x · Cited by 428 · cited 3×
“described the up-regulation of ZO-2 after EcN exposure to the T84 cell line in vitro [10].”
BackgroundClayburgh, D. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24970 · Cited by 426 · cited 1×
“Active fluid absorption is also dependent on intact tight junctions, otherwise a phenomenon called “leak flux diarrhea” occurs”
BackgroundSchultz, M., Veltkamp, C., Dieleman, L. A., Grenther, W. B., Wyrick, P. B., Tonkonogy, S. L., & Sartor, R. B. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200203000-00001 · Cited by 375 · cited 1×
“In the past years, probiotics have been shown to be effective in the treatment of mild to moderately active IBD [18] and to reduce inflammation in animal models of colitis [29,34–36].”
BackgroundSMITH, P. D., LANE, H. C., GILL, V. J., MANISCHEWITZ, J. F., QUINNAN, G. V., FAUCI, A. S., & MASUR, H. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-328 · Cited by 357 · cited 1×
“However, in a number of HIV patients with gastrointestinal complaints no enteropathogen can be identified [3,4].”
BackgroundVolunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques
Levine, M. M., Kaper, J. B., Herrington, D., Losonsky, G., Morris, J. G., Clements, M. L., Black, R. E., Tall, B., & Hall, R. (1988) · Infection and Immunity · doi:10.1128/iai.56.1.161-167.1988 · Cited by 294 · cited 1×
“When cholera toxin deletion mutants of Vibrio cholerae were given to healthy volunteers they still developed mild diarrhea [43].”
BackgroundHavenaar, R., & Huis In’t Veld, J. H. J. (1992) · The Lactic Acid Bacteria Volume 1 · doi:10.1007/978-1-4615-3522-5_6 · Cited by 289
Fasano, A., & Uzzau, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119271 · Cited by 266 · cited 1×
“In addition, it was found that a disruption of the tight junctional complex allowed easier permeation of substances from the lumen [47].”
BackgroundIntestinal permeability, leaky gut, and intestinal disorders
Hollander, D. (1999) · Current Gastroenterology Reports · doi:10.1007/s11894-999-0023-5 · Cited by 258 · cited 1×
“been shown to exhibit increased gut permeability [48,49].”
BackgroundHenker, J., Laass, M., Blokhin, B. M., Bolbot, Y. K., Maydannik, V. G., Elze, M., Wolff, C., & Schulze, J. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0419-x · Cited by 199 · cited 1×
“characterized probiotics, and its therapeutic efficacy and safety have convincingly been proven [12–16].”
BackgroundGrabig, A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D. C., Erckenbrecht, J., Raupach, B., Sonnenborn, U., Eckert, J., Schumann, R. R., et al. (2006) · Infection and Immunity · doi:10.1128/iai.01449-05 · Cited by 198 · cited 1×
“Acute colitis was induced in BALB/c mice by addition of 4–6% dextran sodium sulfate (DSS) (MP Biomedicals, Eschwege, Germany) to drinking water for a period of 8 days, according to a protocol recently described by Grabig et al.”
MethodWu, Z., Nybom, P., & Magnusson, K.-E. (2000) · Cellular Microbiology · doi:10.1046/j.1462-5822.2000.00025.x · Cited by 195
Alberda, C., Gramlich, L., Meddings, J., Field, C., McCargar, L., Kutsogiannis, D., Fedorak, R., & Madsen, K. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.816 · Cited by 166 · cited 1×
“in clinical trials [52].”
Philpott, D. J., McKay, D. M., Mak, W. H., Perdue, M. H., & Sherman, P. M. (1998) · Infection and Immunity · doi:10.1128/iai.66.4.1680-1687.1998 · Cited by 152 · cited 1×
“develop from the disruption of the intestinal epithelial barrier by enteropathogenic bacteria that alter the cellular cytoskeleton [31,32] or affect specific tight junction proteins like ZO-1 [33].”
BackgroundParassol, N., Freitas, M., Thoreux, K., Dalmasso, G., Bourdet‐Sicard, R., & Rampal, P. (2004) · Research in Microbiology · doi:10.1016/j.resmic.2004.09.013 · Cited by 146 · cited 1×
“Probiotics have been shown to reduce the increased intestinal permeability in vitro [51] as well as”
BackgroundResta‐Lenert, S. C., Smitham, J. E., & Barrett, K. E. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00395.2004 · Cited by 146
Intestinal infections in patients with acquired immunodeficiency syndrome
Ren�, E., Marche, C., Regnier, B., Saimot, A. G., Vildé, J., Perrone, C., Michon, C., Wolf, M., Chevalier, T., Vallot, T., et al. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01540353 · Cited by 139 · cited 1×
“However, in a number of HIV patients with gastrointestinal complaints no enteropathogen can be identified [3,4].”
BackgroundProbiotics in inflammatory bowel disease: possible mechanisms of action.
Dotan, I., & Rachmilewitz, D. (2005) · PubMed · Cited by 122
Schultz, M., Strauch, U., Linde, H., Watzl, S., Obermeier, F., Göttl, C., Dunger, N., Grunwald, N., Schölmerich, J., & Rath, H. C. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.2.372-378.2004 · Cited by 120 · cited 1×
“Recently it was demonstrated that EcN, used as a therapeutic for the treatment of ulcerative colitis, ameliorates acute colitis in mice [29].”
BackgroundTransepithelial transport processes at the intestinal mucosa in inflammatory bowel disease
Schürmann, G., Brüwer, M., Klotz, A., Schmid, K. W., Senninger, N. J., & Zimmer, K. ‐. (1999) · International Journal of Colorectal Disease · doi:10.1007/s003840050181 · Cited by 110 · cited 1×
“It has been shown that the impaired barrier function in IBD is associated with an altered TJ structure [7,8,25–28].”
BackgroundWhiting, C. V., Bland, P. W., & Tarlton, J. F. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000164016.98913.7c · Cited by 106 · cited 1×
“Using another murine colitis model, administration of n-3 polyunsaturated fatty acids resulted not only in reduced pathological scores but also an increase of ZO-1 protein expression [56].”
BackgroundIvanov, A. I., Nusrat, A., & Parkos, C. A. (2004) · Novartis Foundation Symposia · doi:10.1002/0470090480.ch9 · Cited by 103 · cited 2×
“intercellular junctions [26,50].”
BackgroundJepson, M. A., Collares‐Buzato, C. B., Clark, M. A., Hirst, B. H., & Simmons, N. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.356-359.1995 · Cited by 102 · cited 1×
“develop from the disruption of the intestinal epithelial barrier by enteropathogenic bacteria that alter the cellular cytoskeleton [31,32] or affect specific tight junction proteins like ZO-1 [33].”
BackgroundStockmann, M., Fromm, M., Schmitz, H., Schmidt, W., Riecken, E., & Schulzke, J. (1998) · AIDS · doi:10.1097/00002030-199801000-00006 · Cited by 102 · cited 1×
“Active fluid absorption is also dependent on intact tight junctions, otherwise a phenomenon called ‘‘leak flux diarrhea’’ occurs [39–41].”
BackgroundIntestinal immunity ofEscherichia coliNISSLE 1917: a safe carrier for therapeutic molecules
Westendorf, A. M., Gunzer, F., Deppenmeier, S., Tapadar, D., Hunger, J. K., Schmidt, M. A., Buer, J., & Bruder, D. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.10.023 · Cited by 98 · cited 1×
“characterized probiotics, and its therapeutic efficacy and safety have convincingly been proven [12–16].”
BackgroundSelf-citationReview article: Intestinal permeability in Crohn's disease
Meddings, J. B. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1997.tb00808.x · Cited by 98
Wu, Z., Milton, D. L., Nybom, P., Sjö, A., & Magnusson, K. (1996) · Microbial Pathogenesis · doi:10.1006/mpat.1996.0047 · Cited by 90 · cited 1×
“Later studies revealed yet another agent from Vibrio cholerae, the HA/ protease, that specifically interferes with the tight junction proteins occludin and ZO-1 resulting in barrier disruption [45,46].”
BackgroundMechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation
Barmeyer, C., HARREN, M., Schmitz, H., Heinzel-Pleines, U., Mankertz, J., Seidler, U. E., Horak, I. D., Wiedenmann, B., Fromm, M., & Schulzke, J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00141.2003 · Cited by 86 · cited 1×
“intercellular junctions [26,50].”
Self-citationEpithelial Tissue Chimerism after Human Hematopoietic Cell Transplantation Is a Real Phenomenon
Spyridonidis, A., Schmitt-Graeff, A. H., Tomann, T., Dwenger, A., Follo, M., Behringer, D. M., & Finke, J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63203-8 · Cited by 77 · cited 1×
“Pooled IECs were centrifuged with HBSS/PBS; the pellet was resuspended in FACS buffer (PBS+2% FCS+2 mM EDTA) and stained with anti-CD45 APC antibody (BD Biosciences, Heidelberg, Germany) to deplete hematopoietic cells [24].”
MethodIntestinal permeability in Crohn's disease.
Murphy, M., EASTHAM, E. J., NELSON, R. L., Pearson, A., & Laker, M. F. (1989) · Archives of Disease in Childhood · doi:10.1136/adc.64.3.321 · Cited by 76
AMP-18 protects barrier function of colonic epithelial cells: role of tight junction proteins
Walsh-Reitz, M. M., Huang, E., Musch, M. W., Chang, E. B., Martin, T. E., Kartha, S., & Toback, F. G. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00013.2005 · Cited by 68 · cited 2×
“This hypothesis is consistent with recently published data regarding the antrum mucosal protein (AMP)-18 that ameliorates DSS colitis in mice and also enhances accumulation of occludin and ZO-1 in TJ domains in vitro [55].”
BackgroundResultSchmitz, H., Rokos, K., Florian, P., Gitter, A. H., Fromm, M., Scholz, P., Ullrich, R., Zeitz, M., Pauli, G., & Schulzke, J. (2002) · AIDS · doi:10.1097/00002030-200205030-00004 · Cited by 68 · cited 1×
“as potential cause for non-infectious diarrhea in HIVinfected patients, in addition to mucosal transformation with a consecutive malabsorptive mechanism [42].”
BackgroundKapembwa, M. S., Fleming, S. C., Sewankambo, N. K., Serwadda, D., Lucas, S. B., Moody, A. H., & Griffin, G. E. (1991) · Clinical Science · doi:10.1042/cs0810327 · Cited by 65
Molecular Mechanisms of Disturbed Electrolyte Transport in Intestinal Inflammation
Seidler, U. E., Lenzen, H., Cinar, A., Tessema, T. S., Bleich, A., & Riederer, B. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.024 · Cited by 59 · cited 1×
“Na absorptive transporters are compromised during acute colitis, and this is one major reason for diarrhea during colonic inflammation [38].”
BackgroundSelf-citationJepson, M. A., Schlecht, H., & Collares‐Buzato, C. B. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7202-7208.2000 · Cited by 58 · cited 1×
“develop from the disruption of the intestinal epithelial barrier by enteropathogenic bacteria that alter the cellular cytoskeleton [31,32] or affect specific tight junction proteins like ZO-1 [33].”
BackgroundDislocation of tight junction proteins without F-actin disruption in inactive Crohn's disease
Oshitani, N., Watanabe, K., Nakamura, S., Fujiwara, Y., Higuchi, K., & Arakawa, T. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.15.3.407 · Cited by 55 · cited 1×
“apical to the basolateral side in CD patients [53] indicating an”
BackgroundEstablishment of long-term primary cultures of human small and large intestinal epithelial cells.
Rogler, G., Daig, R., Aschenbrenner, E., Vogl, D., Schlottmann, K., Falk, W., Gross, V., Schölmerich, J., & Andus, T. (1998) · PubMed · Cited by 52
Self-citationBrownlow, L. (1941) · Public Administration Review · doi:10.2307/973073 · Cited by 45
Increased Colonic Permeability in Patients with Ulcerative Colitis: An in Vitro Study
Nejdfors, P. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850171701 · Cited by 40 · cited 1×
“It has been shown that the impaired barrier function in IBD is associated with an altered TJ structure [7,8,25–28].”
BackgroundBleich, A., Sundberg, J. P., Smoczek, A., von Wasielewski, R., de Buhr, M. F., Janus, L. M., Julga, G., Ukena, S. N., Hedrich, H. J., & Gunzer, F. (2007) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2007.00560.x · Cited by 24 · cited 1×
“Gnotobiotic BALB/c mice were obtained from colonies maintained germfree at the Central Animal Facility of Hannover Medical School, as described previously [20].”
MethodSelf-citationChan, L. Y., & Sung, J. J. �. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.122293000.x · Cited by 10
Gnotobiotic Piglets as an Animal Model for Oral Infection with O157 and Non-O157 Serotypes of STEC
Gunzer, F., Hennig‐Pauka, I., Waldmann, K.-H., & Mengel, M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-316-x:307 · Cited by 9 · cited 1×
“2610(9) CFU/ml) from an overnight culture diluted 1:500 in LB media [21].”
BackgroundSelf-citation
Cited by
Intestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755
“EcN also increases claudin-14 expression in the epithelial TJ and its effect is mediated via TcpC via PKC-zeta and the MAPK ERK1/2.”
BackgroundInfluentialGut microbiota, intestinal permeability, and systemic inflammation: a narrative review
Di Vincenzo, F., Del Gaudio, A., Petito, V., Lopetuso, L. R., & Scaldaferri, F. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03374-w · Cited by 1,498
“…on the intestinal barrier; indeed, E. coli strain C25 increases intestinal permeability, while E. coli Nissle 191 7 stimulates Zonu-lin-2 (ZO-2), and ZO-1 expression, and confers protection against DSS-colitis-associated increase of mucosal permeability to luminal substances in mice models [16].”
BackgroundRegulation of intestinal epithelial permeability by tight junctions
Suzuki, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1070-x · Cited by 1,343
“experimental mouse model of colitis [223, 224].”
Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components1,2
Ulluwishewa, D., Anderson, R. C., McNabb, W. C., Moughan, P. J., Wells, J. M., & Roy, N. C. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.135657 · Cited by 1,177
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110
Metadata
- Authors
- Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., Suerbaum, S., Buer, J., Gunzer, F., & Westendorf, A. M.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Helmholtz Centre for Infection Research (DE)
- University Hospital Zurich (CH)
- Essen University Hospital (DE)
- Technische Universität Dresden (DE)
- Corresponding author
- Ukena, Sya N.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-12-12
- Volume
- 2
- Issue
- 12
- Pages
- e1308
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2110898
- OpenAlex
- W2149362751
- Cited by
- 482
- References
- 60
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 24 · 2023: 27 · 2022: 39 · 2021: 37 · 2020: 26 · 2019: 26 · 2018: 24 · 2017: 31 · 2016: 25 · 2015: 24 · 2014: 30 · 2013: 22 · 2012: 25
- FWCI
- 30.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- HZI (Helmholtz Centre for Infection Research) (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB621)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Escherichia coli Nissle 1917, probiotics, leaky gut, intestinal barrier, tight junctions, ZO-1, ZO-2, intestinal epithelial cells, DSS-induced colitis, mucosal permeability, gnotobiotic mice, inflammatory bowel disease, sodium uptake, Evans blue
- MeSH terms
- Animals, Base Sequence, Colitis, Escherichia coli, Female, Fluorescent Antibody Technique, Germ-Free Life, Intestinal Mucosa, Mice, Inbred BALB C, Blotting, Western, DNA Primers, Probiotics, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.